WuXi Biologics (Cayman) Inc ADR WXXWY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $3.25
- Day Range
- $3.12–3.23
- 52-Week Range
- $3.12–13.25
- Bid/Ask
- $3.18 / $3.26
- Market Cap
- $6.72 Bil
- Volume/Avg
- 62,264 / 250,275
Key Statistics
- Price/Earnings (Normalized)
- 9.51
- Price/Sales
- 2.96
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 4.43%
Company Profile
WuXi Biologics is one of the largest global biologics CRDMOs. WuXi Biologics, incorporated in 2014 following the reorganization of WuXi PharmaTech, later known as WuXi AppTec, now has global revenue of CNY 17 billion. North America represented 47.4% of total revenue in 2023. It adopts the follow and win the molecule strategy by providing end-to-end services, from drug discovery to commercial manufacturing. It also adopts a global dual-sourcing strategy by providing drug products and large-scale drug substance manufacturing.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Large Growth
- Total Number of Employees
- 12,740
- Website
- https://www.wuxibiologics.com
Competitors
Valuation
Metric
|
WXXWY
|
01801
|
01177
|
---|---|---|---|
Price/Earnings (Normalized) | 9.51 | — | 17.25 |
Price/Book Value | 1.23 | 4.45 | 1.44 |
Price/Sales | 2.96 | 8.66 | 1.65 |
Price/Cash Flow | 7.46 | — | 8.60 |
Price/Earnings
WXXWY
01801
01177
Financial Strength
Metric
|
WXXWY
|
01801
|
01177
|
---|---|---|---|
Quick Ratio | 1.79 | 3.21 | 0.93 |
Current Ratio | 2.20 | 3.96 | 1.00 |
Interest Coverage | 40.97 | −14.05 | 9.68 |
Quick Ratio
WXXWY
01801
01177
Profitability
Metric
|
WXXWY
|
01801
|
01177
|
---|---|---|---|
Return on Assets (Normalized) | 9.91% | −9.10% | 3.98% |
Return on Equity (Normalized) | 14.09% | −15.75% | 8.61% |
Return on Invested Capital (Normalized) | 11.82% | −12.17% | 5.64% |
Return on Assets
WXXWY
01801
01177
Biotechnology Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Wflhrbsr | Dqh | $562.4 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Bqqflcdb | Kvggcdt | $103.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Qxfdvxcf | Fkrghw | $99.5 Bil | |
MRNA
| Moderna Inc | Dwfknpp | Kytg | $38.8 Bil | |
ARGX
| argenx SE ADR | Cfgjvysm | Bqs | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Lcxvgllvb | Pwp | $21.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Kxycvgzj | Zqpmdy | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Tgsvgjfl | Nyzhb | $17.3 Bil | |
RPRX
| Royalty Pharma PLC Class A | Gqcnkrlh | Zkhyhn | $12.5 Bil | |
INCY
| Incyte Corp | Trrkvsfkp | Tlhqyn | $11.6 Bil |